IL22 and Guillain-Barre syndrome: IL-22 affects the outcome of several diseases, such as multiple sclerosis [13], psoriasis [14], inflammatory bowel disease (IBD) [14], Guillain-Barré syndrome (GBS) [15], and West Nile encephalitis [16].